Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Schlitt A, Blankenberg S, Yan D, von Gizycki H, Buerke M, Werdan K, Bickel C, Lackner KJ, Meyer J, Rupprecht HJ, Jiang XC Nutr Metab (Lond) 2006, 3:5 [Full text] [PubMed] [Related articles]
|
No citations for this article were found in PubMed Central.
|